Health Care & Life Sciences » Biotechnology | MorphoSys AG

MorphoSys AG

MorphoSys AG
Stock Exchange Other OTC
EPS
 $2.18
Market Cap
 $3.17 B
Shares Outstanding
 31.81 M
Public Float
 -
MorphoSys AG
Stock Exchange Xetra Stock Exchange
EPS
 EUR1.9
Market Cap
 EUR2.85 B
Shares Outstanding
 31.84 M
Public Float
 30.96 M
MorphoSys AG
Stock Exchange SIX Swiss Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 31.81 M
Public Float
 -

Profile

Address
Semmelweisstraße 7
Planegg Bayern (Bavaria) 82152
Germany
Employees -
Website http://www.morphosys.de
Updated 07/08/2019
MorphoSys AG engages in the development of antibodies for therapeutic, diagnostics, and research applications. It operates through the Proprietary Development and Partnered Discovery segments. The Proprietary Development segment combines proprietary research and development of therapeutic compounds.

Financials

View All
Created with Highcharts 5.0.14MorphoSys AGNet Income. Fiscal year is January-December. All values EUR Thousands.7 3717 3713 0133 01314 90114 90160 38360 38369 82669 82656 17256 172201320142015201620172018020k40k60k80k
Created with Highcharts 5.0.14MorphoSys AGSales/Revenue. Fiscal year is January-December. All values EUR Thousands.77 96077 96063 97863 978106 223106 22349 74449 74466 79066 79076 44276 442201320142015201620172018025k50k75k100k125k

George S. Golumbeski
Member-Supervisory Board
Michael Brosnan
Member-Supervisory Board
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.